People
Jeffrey S. Rosenberg is a trial litigator whose practice focuses on complex business and commercial litigation, with emphasis on securities, shareholder, and Delaware litigation. He defends a broad spectrum of commercial litigation and has extensive experience representing companies and their officers and directors in shareholder disputes such as securities class actions, derivative lawsuits alleging breaches of fiduciary duties, challenges to mergers and acquisitions, and books and records demands. He also advises boards of directors and their committees in conducting internal investigations and evaluating and responding to shareholder demands. He further represents companies in litigation and enforcement actions involving the government, principally in the securities and financial sectors.
Mr. Rosenberg has successfully represented a wide variety of clients in the banking, hospitality, manufacturing, technology, defense, aerospace, health care, biotechnology, cryptocurrency, food and beverage, and consulting industries in federal and state courts, investigations, and enforcement matters.
Mr. Rosenberg has been recognized in the Lawdragon 500 Leading Litigators in America for his work in "Business & Commercial Litigation, esp. Delaware" and in Best Lawyers: Ones to Watch in America in multiple practice areas. He regularly publishes articles on developments in Delaware law and has co-authored treatise chapters on securities, derivative, and Delaware litigation. Prior to joining the firm, Mr. Rosenberg was a litigation associate at Gibson, Dunn & Crutcher LLP.
Mr. Rosenberg is a cum laude graduate of the Georgetown University Law Center, where he served as the solicitations editor of the Georgetown Journal of International Law. He received a Bachelor of Arts degree, with honors, from Johns Hopkins University with a double major in Classics and Philosophy. While an undergraduate, he concurrently completed and graduated with a Master of Arts degree in Classics.
While pursuing his law degree, Mr. Rosenberg worked as a consultant providing homeland security, critical infrastructure protection, incident and emergency management, strategic and operational policy and planning, and enterprise risk management advice to public and private sector clients.
Mr. Rosenberg is admitted to practice law in the Commonwealth of Virginia and the District of Columbia, and before the U.S. Court of Appeals for the Fourth Circuit, U.S. District Court for the District of Columbia, U.S. District Court for the Eastern District of Virginia, U.S. District Court for the District of Maryland, and the U.S. District Court for the Western District of Virginia.
J.D., Georgetown University Law Center
B.A., Johns Hopkins University
M.A., Johns Hopkins University
District of Columbia
U.S. Court of Appeals for the Fourth Circuit
U.S. District Court for the District of Columbia
U.S. District Court for the District of Maryland
U.S. District Court for the Eastern District of Virginia
U.S. District Court for the Western District of Virginia
Virginia
Won dismissal of a securities class action, which was affirmed on appeal, and two parallel derivative actions claiming that Marriott made false and misleading statements concerning its susceptibility to cyberattacks.
Won dismissal of a securities class action alleging Progenity (now Biora), a biotechnology developer and provider of testing products, made false statements in its offering documents under Section 11.
Won dismissal of a securities class action assailing Northwest Biotherapeutics' public statements about the development of its products.
See moreWon dismissal of a securities class action, which was affirmed on appeal, and two parallel derivative actions claiming that Marriott made false and misleading statements concerning its susceptibility to cyberattacks.
Won dismissal of a securities class action alleging Progenity (now Biora), a biotechnology developer and provider of testing products, made false statements in its offering documents under Section 11.
Won dismissal of a securities class action assailing Northwest Biotherapeutics' public statements about the development of its products.
See moreJ.D., Georgetown University Law Center
B.A., Johns Hopkins University
M.A., Johns Hopkins University
District of Columbia
U.S. Court of Appeals for the Fourth Circuit
U.S. District Court for the District of Columbia
U.S. District Court for the District of Maryland
U.S. District Court for the Eastern District of Virginia
U.S. District Court for the Western District of Virginia
Virginia